Delivery Order SPE2DB22D3301-SPE2DB24FY9DL

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,641.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of Lyrica 100 mg capsules, with a completion date of April 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical as a firm fixed price delivery order for the supply of 100 mg Lyrica capsules. The contract has a potential value of $2,397.92 and a performance period through February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $1,177.02 and is for the delivery of Lyrica 25 mg capsules. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside award. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,778.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 100 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4,562,300 units of Lyrica 50 mg capsules. The $3,458.71 firm fixed-price delivery order has a completion date of September 26, 2023 and is not associated with any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,469.42 firm-fixed price delivery order is for the supply of 4,564,829,527 units of the prescription medication Lyrica (pregabalin) 100 mg capsules. This award falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,549.53 firm fixed-price delivery order is for 4,567,888,073 units of the drug Lyrica 150 mg capsules. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) on August 9, 2024. The $3,497.90 firm fixed-price delivery order is for Lyrica 75 mg capsules, a prescription medication used to treat certain types of nerve pain. The contract has an ultimate completion date of August 12, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lyrica 25 mg capsules to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order has a ceiling value of $1,177.02 and a completion date of May 19, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued up to $1,146.00, is for the delivery of Lyrica 150 mg capsules. This is a firm fixed price, delivery order contract with an ultimate completion date of October 1, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a large pharmaceutical distributor, has been awarded...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9DL
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $2,154.12, provides the Defense Logistics Agency (DLA) with Lyrica 100 mg capsules. The contract is a firm-fixed price delivery order, with a completion date of June 25, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 9/23/24, 9:49 AM